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Background/aim: Evidence-based guidance is likely to significantly improve patient care. We aimed to characterize the adequacy of
standard diagnostic methods and treatment in children with acute bacterial meningitis (ABM) in Turkey.
Materials and methods: We conducted a retrospective study among children 1 month to 5 years old hospitalized with ABM in İstanbul.
The World Health Organization case definition and laboratory criteria were used for diagnosis.
Results: Of the 283 cases, 250 were probable and 33 (11.2%) were confirmed as bacterial meningitis. The majority of patients (92%)
were treated at 9 governmental hospitals and the remaining 21 at 2 university hospitals. Blood culture, cerebrospinal fluid (CSF) culture,
and CSF Gram smear examinations were performed in 68%, 87%, and 13% of the cases, respectively. A third-generation cephalosporin,
alone or in combination with other antibiotics, was the drug of choice in 90% of cases. Dexamethasone was given as adjunctive therapy
in 43%. Initial antibiotics were modified during the course of treatment for 43 patients, with culture-confirmed indications for only 5
of them.
Conclusion: Recommended laboratory tests including blood culture and CSF Gram smears were insufficiently performed. Appropriate
antibiotics were used in the majority of cases. Better identification of the causative pathogens will improve stewardship of antimicrobial
therapy.
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1. Introduction
Acute bacterial meningitis (ABM) is a medical emergency
requiring immediate diagnostic steps and appropriate
therapy (1,2). Epidemiology of ABM in children has
changed, especially following the introduction of
Haemophilus influenzae type B (Hib) and pneumococcal
conjugate vaccines in the routine childhood immunization
schedule. Recognition of changing epidemiology and
bacterial resistance patterns is important for decisions on
empirical therapy.
Evidence-based medicine has been defined as the
integration of the best research evidence with clinical
expertise and patient values (3). International guidelines
providing clinicians with recommendations are presented
for several diseases including bacterial meningitis (2,4).
Several studies determining the etiology and prognostic
factors in children with bacterial meningitis have been
performed in Turkey (5,6). Nevertheless, practice patterns
for management of childhood ABM have not been
* Correspondence: barisbulent98@yahoo.com
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evaluated previously. Health care facilities have different
resources for doing microbiological diagnosis in Turkey
with almost no estimates of appliance of standard early
diagnostic methods and treatment modalities. In this
study, we aimed to identify how accurate the utility of
diagnostic methods and treatment in children with ABM
was in comparison to recommendations presented by
international guidelines.
2. Materials and methods
We reviewed the records of children of 1 month to 5
years of age who were admitted to 11 tertiary hospitals
in İstanbul with a diagnosis of ABM during 2005. The
study centers included 2 university hospitals (Marmara
University Hospital, Cerrahpaşa Medical Faculty
Hospital) and 9 governmental hospitals (Bezmialem Vakıf
Gureba Training and Research Hospital, Zeynep Kamil
Training and Research Hospital, Bakırköy Maternity and
Children Training and Research Hospital, Haseki Training
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and Research Hospital, Haydarpaşa Numune Training
and Research Hospital, Şişli Etfal Training and Research
Hospital, Kartal Lütfi Training and Research Hospital,
Göztepe Training and Research Hospital, Okmeydanı
Training and Research Hospital). These 11 centers are
among the major tertiary referral centers for treatment
of pediatric patients in İstanbul. Clinical and laboratory
criteria of the World Health Organization (WHO) were
used for diagnosis of bacterial meningitis (7). Clinical
description included acute onset of fever, headache,
and one of the following signs: neck stiffness, altered
consciousness, or other meningeal signs. Laboratory
criteria included: 1) culture [isolation of a bacterial
pathogen from a normally sterile clinical specimen such as
cerebrospinal fluid (CSF) or blood]; 2) antigen detection
(isolation of a bacterial antigen from normally sterile
fluid, i.e. CSF or blood); 3) Gram stain results. A probable
case was defined as presence of clinical findings with CSF
examination showing at least one of the following: 1)
turbid appearance; 2) leukocytosis (>100 cells/mm3); 3)
leukocytosis (10–100 cells/mm3) AND either an elevated
protein level (100 mg/dL) or decreased glucose (<40
mg/dL). A confirmed case was defined as laboratoryconfirmed by growing (i.e. culturing) or identifying (i.e.
by Gram stain or antigen detection methods) a bacterial
pathogen (Hib, pneumococcus, or meningococcus) in the
CSF or from the blood in a child with a clinical syndrome
consistent with bacterial meningitis. Both probable and
confirmed bacterial meningitis cases were included in the
study. Patients with recurrent meningitis, posttraumatic

meningitis, shunt-related meningitis, and underlying
illnesses were excluded. Data including diagnostic
tests, etiological organisms, neuroimaging procedures,
corticosteroid use, antibiotics used initially, and reasons
for modification of antibiotics were collected from patient
abstracts and tabulated according to centers.
3. Results
Of the 283 patients with ABM, the majority (92%) were
treated at 9 governmental hospitals and the remaining 21
patients were treated at 2 university hospitals. The number
of patients treated at each center is given in Table 1. Maleto-female ratio was 2.17 and median age was 12 months.
Prior to admission, 105 (38%) patients had received
antibiotics (70% parenteral). A total of 194 (92%) patients
had a complete blood count examination with differential
and platelet count. C-reactive protein was measured in
82% of cases. Gram smears of CSF samples were examined
in 38 (13%) of cases, while 248 (87.6%) patients had a CSF
culture taken and blood cultures were available for 194
(68.5%) patients. Only patients treated at a single center
had CSF latex agglutination test (LAT) results. The LAT
was not performed at the remaining centers.
An etiological organism could be identified in 33
(11.2%) patients. One-third of these patients had received
antibiotics before admission. The most common organisms
were Hib (36.3%), Streptococcus pneumonia (30.3%), and
Neisseria meningitidis (21%) (Table 2). Among 19 patients
with positive CSF cultures, 8 (42%) had also bacteria
detected in their blood cultures. Seven out of 10 patients

Table 1. Diagnostic methods and drugs used for treatment of meningitis in 11 centers.
Center no. (number of patients)
1
(9)

2
(41)

3
(23)

4
(19)

5
(55)

6
(30)

7
(25)

8
(40)

9
(5)

10
(16)

11
(20)

Diagnostic method
%CSF culture
%Blood culture
%CSF Gram smear

77
77
0

100
87
9.7

91
86
21

94
84
5.2

70
43
1.8

100
96
0

84
72
3

100
75
5

100
100
100

93
43
81

55
10
5

Cranial imaging
%CT
%MRI

0
7.8

12
4.8

34.7
4.3

15
5.2

49
18

16
6.6

28
12

25
2.5

0
0

37
12

15
0

Antibiotics used
%CFT/CTX
%SAM+CFT/CTX
%VA+CFT/CTX %
P+CHL

55.6
44.4
0
0

19.5
56.1
0
9.8

73.9
26.1
0
0

84.2
5.3
0
10.5

0
81.8
7.3
5.5

60
3.3
16.7
3.3

52
16
24
0

85
7.5
0
0

100
0
0
0

6.7
26.7
13.3
53.3

60
20
20
0

%Dexamethasone

100

44.4

52.4

73.7

33.3

66.7

70.8

57.9

100

35.7

80

CFT: Ceftriaxone, CTX: cefotaxime, SAM: ampicillin-sulbactam, VA: vancomycin, P: penicillin, CHL: chloramphenicol.
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Table 2. Bacterial etiology in children with acute bacterial meningitis.

Pathogen

Prior antibiotics use
Yes

No

Haemophilus influenzae type B

2

10

Streptococcus pneumonia

5

5

Neisseria meningitidis

1

6

Other

2

2

Total

10

23

Other: 1 Group D streptococci, 2 Staphylococcus aureus, 1 Escherichia coli.

with positive blood cultures (70%) also had positive CSF
cultures. Bacteria were detected by Gram smears in 17
patients, and in 7 of these (40%), CSF and blood cultures
remained sterile. Hib was identified by LAT in 3 patients.
A total of 111 (40%) patients were evaluated with
neuroimaging procedures, including ultrasonography in
41 (14%), computerized tomography (CT) in 74 (26%),
and magnetic resonance imaging (MRI) in 23 (8%) of the
cases. The majority of cranial imaging procedures were
performed during hospital stay due to complaints such as
ongoing fever or convulsions with suspicion of emergence
of a complication. Few patients had cranial imaging at the
beginning of the treatment before lumbar puncture (LP)
due to pathological findings in fundoscopy or physical
examination. A second LP was performed in 115 (40.6%)
patients and 107 (37.8%) patients had LP 3 or more times,
while 60% of patients had LP examination at the end of
treatment.
Fifteen different antibiotic regimens were used in
treatment. Ninety percent of patients received ceftriaxone/
cefotaxime alone or in combination with other antibiotics.
A penicillin and chloramphenicol combination was
used in 18 (6%) cases. Dexamethasone was given as
adjunctive therapy in 117 (43%) cases (Table 1). During
treatment, antibiotics were modified in 43 (15.1%) cases.
The most common reasons for antibiotic modification
were persistent or breakthrough fevers (37%); only 5
patients had culture-confirmed indications for antibiotic
modification. Primary antibiotics were changed due to
insufficient response in CSF findings, subdural effusion,
and convulsions in 32%, 20%, and 17% of the patients,
respectively.
Thirty-eight patients (13.4%) developed neurologic
complications and 2 patients died. Sequelae were detected
in 26% of patients. Prognostic factors of patients with
ABM were presented in a previous report (8).

766

4. Discussion
An accurate laboratory confirmation of the etiology in
bacterial meningitis is essential. CSF culture should be
obtained in all patients with suspicion of ABM despite
the absence of pleocytosis (9). In a study of 128 children
with ABM, CSF cultures were positive in 97% of patients
without previous antibiotic therapy, 67% of patients who
received oral antibiotics, and 56% of patients who received
parenteral antibiotics (10). Isolation of bacteria from blood
culture in a patient with CSF pleocytosis also confirms the
diagnosis (9,11). In the study by Nigrovic et al., of the 85
patients who received antibiotics before LP, 46 (54%) had
blood culture specimens obtained before administration
of antibiotics revealing the bacterial pathogen in 35% of
them (12). In the present study, almost 90% of the patients
had CSF culture examinations; however, blood culture
was taken in 68% of cases. Bacteria can be detected by
Gram smears in 60%–90% of patients with ABM (13).
The presence of an organism upon CSF Gram stain may
suggest bacterial etiology 1 day or more before culture
results are available (14). Only 38 (13%) patients had CSF
Gram smear examinations; nevertheless, 7 patients who
had negative CSF and blood cultures were confirmed by
CSF Gram smear examinations, proving the importance
of CSF Gram smear. In a previous analysis of 218 episodes
of ABM, CSF and blood cultures were negative but Gram
stains were positive in 54 (24.8%) cases (15). In a study
evaluating the sensitivity of the bacterial meningitis score
in 889 children with bacterial meningitis, CSF Gram stain
was positive in 89.1% of cases (16). CSF polymerase chain
reaction (PCR) analysis is also very useful for defining
bacterial etiology. Among 408 children with bacterial
meningitis, PCR analysis of CSF was the most sensitive
method, confirming 59.6% of the cases (5). None of the
patients in our study had CSF PCR results. CSF antigen
detection tests are not recommended routinely in the
diagnosis of bacterial meningitis, but can be helpful in
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patients pretreated with antibiotics (17). Additional use of
LAT identified 3 patients with Hib meningitis who were
culture-negative.
In patients suspected of having ABM with
contraindications for LP, CT (or MRI) scanning of
the brain should be the first step of management (4).
Neuroimaging may be indicated in the presence of focal
neurological signs, persistently positive CSF cultures
despite appropriate antibiotic therapy, persistent elevation
of CSF neutrophils (>30%–40%) after more than 10 days of
therapy, and recurrent meningitis (18). About one-fourth
of the patients in this study had undergone cranial CT
imaging, revealing subdural effusion as the most common
pathology. The majority of cranial imaging procedures
were performed during hospital stay because of complaints
such as ongoing fever or convulsions with a suspicion of
development of a complication. In a previous study, Uysal
et al. reported that 42 out of 125 patients had cranial CT
examination, revealing pathology in 20% of them (6).
A third-generation cephalosporin is recommended as
the first-line agent in children older than 1 month of age
with community-acquired bacterial meningitis (4). The
use of ceftriaxone or cefotaxime in 90% of the patients is in
accordance with literature. If penicillin- or cephalosporinresistant pneumococcus is suspected, in geographic
regions or in patients with a recent travel history to
countries with high rates of penicillin and ceftriaxone
resistance (e.g., the United States), the use of ceftriaxone
or cefotaxime plus vancomycin is recommended (4,19,20).
Resistance to cefotaxime was reported as 4% in isolates
from children with invasive pneumococcal disease in
Turkey (21). Ampicillin plus chloramphenicol can be used
when third-generation cephalosporins are not available
and the locally isolated bacteria do not show significant
resistance (4). In our study, combination regimens were
used in 54% of the cases; however, surveys in Canada
and the United States showed that over 90% of physicians
preferred monotherapy with ceftriaxone or cefotaxime
for treatment of meningitis in children after the neonatal
period (22).
Nearly half of the patients that we reviewed had
received dexamethasone. Except for hearing loss after
Hib meningitis, no clear evidence establishes that
dexamethasone alters long-term sequelae of meningitis (2).
Decisions regarding the administration of dexamethasone
should be individualized depending on careful analysis
of risks and benefits. In a multicenter study including 27
tertiary care children’s hospitals located in 18 US states
and the District of Columbia, adjuvant corticosteroid
therapy was not associated with time to death or time to
hospital discharge (23). Despite opposite results in several
metaanalyses, dexamethasone is advised in the European
guideline (4). Dexamethasone administered before the

first parenteral antibiotic dose was shown to decrease
nitric oxide production in CSF during bacterial meningitis
(24). Çetin et al. demonstrated that CSF nitrite level could
have a prognostic effect in meningitis (25).
The most common reasons for antibiotic modification
in this study were fever and abnormalities in repeat CSF
examinations. A repeat CSF examination is recommended
for patients who have a poor clinical response despite 24–
36 h of appropriate antimicrobial therapy, for children with
gram-negative bacillary meningitis, and for those with
cephalosporin resistant pneumococci or pneumococcal
meningitis treated with dexamethasone (2). In addition to
glucose and protein abnormalities, CSF pleocytosis may be
evident even after appropriate antibacterial therapy (26).
If at the conclusion of the standard duration of treatment
CSF examination shows >30% neutrophils or CSF glucose
of <20 mg/dL, extension of the duration of treatment is
indicated (1). The duration of fever in meningitis is usually
4–6 days after the initiation of appropriate therapy. Fever
may be due to development of a suppurative complication
or of discontinuation of dexamethasone, but in many cases
a specific cause of prolonged fever cannot be determined
(27).
We detected that the rate of microbiological
confirmation was only 11.2%. The WHO criteria for
confirmation of bacterial meningitis, including blood
culture, CSF Gram smears, and antigen detection tests,
were insufficiently applied. Prior use of antibiotics before
LP, problems in direct plating of CSF at bed site, and
storage and laboratory support of CSF samples could have
negatively affected culture positivity. Availability of highly
sensitive methods such as PCR will increase detection of
bacterial pathogens. More than half of patients had LP
examination at the end of treatment, which is not routinely
recommended. Antibiotic modifications depended on
factors other than microbiological results. Identification
of the causative pathogen may provide definitive therapy
with a narrow spectrum of agents with decreased toxicity,
decreased selective pressure, and decreased cost.
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